Balentine LLC’s iShares Global Healthcare ETF IXJ Stock Holding History

Balentine LLC’s Portfolio IXJ Stock Details IXJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15	Closed	-$1K	–	674
2022 Q3	$1K	Buy	+15	New	+$1.21K	﹤0.01%	594

Other funds holding IXJ

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

RBA

Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balentine LLC's IXJ Position: Q4 2022 in Review

Balentine LLC sold out of iShares Global Healthcare ETF (IXJ) in Q4 2022, closing a stake of 15 shares — an estimated $1K sold.

Balentine LLC first reported a position in IXJ in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 270 funds tracked by Wall St. Rank hold IXJ as of Q4 2022.

Balentine LLC reported no remaining iShares Global Healthcare ETF position as of Q4 2022 after selling out during the quarter.
Balentine LLC sold 15 iShares Global Healthcare ETF shares in Q4 2022, an estimated $1K.
Balentine LLC first reported a position in iShares Global Healthcare ETF in Q3 2022 and held it in 1 quarter.
Balentine LLC's iShares Global Healthcare ETF position peaked at $1K in Q3 2022.
270 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q4 2022.

Based on Balentine LLC's 13F filing for Q4 2022, filed 31 Jan 2023.